- Home
- IQV vs IDXX Comparison
IQV vs IDXX Comparison
Compare IQV & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- IDXX
- Stock Information
- Founded
- IQV 1982
- IDXX 1983
- Country
- IQV United States
- IDXX United States
- Employees
- IQV N/A
- IDXX N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IQV Health Care
- IDXX Health Care
- Exchange
- IQV Nasdaq
- IDXX Nasdaq
- Market Cap
- IQV 31.6B
- IDXX 34.1B
- IPO Year
- IQV 2013
- IDXX 1991
- Fundamental
- Price
- IQV $174.35
- IDXX $426.25
- Analyst Decision
- IQV Strong Buy
- IDXX Buy
- Analyst Count
- IQV 18
- IDXX 8
- Target Price
- IQV $248.72
- IDXX $533.75
- AVG Volume (30 Days)
- IQV 1.5M
- IDXX 710.1K
- Earning Date
- IQV 05-01-2025
- IDXX 04-30-2025
- Dividend Yield
- IQV N/A
- IDXX N/A
- EPS Growth
- IQV 2.74
- IDXX 6.06
- EPS
- IQV 7.49
- IDXX 10.67
- Revenue
- IQV $15,405,000,000.00
- IDXX $3,897,504,000.00
- Revenue This Year
- IQV $4.25
- IDXX $7.76
- Revenue Next Year
- IQV $6.17
- IDXX $8.05
- P/E Ratio
- IQV $23.21
- IDXX $39.74
- Revenue Growth
- IQV 2.81
- IDXX 6.46
- 52 Week Low
- IQV $169.11
- IDXX $398.50
- 52 Week High
- IQV $252.88
- IDXX $548.88
- Technical
- Relative Strength Index (RSI)
- IQV 35.36
- IDXX 49.97
- Support Level
- IQV $169.37
- IDXX $411.59
- Resistance Level
- IQV $188.39
- IDXX $424.17
- Average True Range (ATR)
- IQV 4.83
- IDXX 9.10
- MACD
- IQV -0.79
- IDXX 1.03
- Stochastic Oscillator
- IQV 25.16
- IDXX 81.52
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.